PPARGC1A and Insulin resistance: Taken together, it is conceivable the activation of PPARβ/δ, which works synergistically with AMPK and PGC-1α, represents a potential method of improving mitochondrial function (and BCAA metabolism), which is often suppressed during insulin resistance.